'Tumor models' diaporamas de présentation

The Role of Preclinical Models to Identify Novel Therapeutics in Rare Cancers

369 views • 23 slides

The Role of Preclinical Models to Identify Novel Therapeutics in Rare Cancers

333 views • 23 slides

Patient Derived Xenograft/PDX Models Market worth 167.6 Million USD by 2022

The report "Patient Derived Xenograft/PDX Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO) - Global Forecast to 2022"

166 views • 7 slides

Patient Derived Xenograft Models Market Worth 167.6 Million USD by 2022

According to a new market research report "Patient Derived Xenograft/PDx Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO) - Global Forecast to 2022", published by MarketsandMarketsu2122, the market is expected to reach USD 167.6 Million by 2022 from an estimated USD 77.4 Million in 2017, at a CAGR of 16.7%.

27 views • 2 slides